fam-trastuzumab-deruxtecan-nxki - Clinical Oncology News

×

ADVERTISEMENT

Register Log in

Inflammatory Diet Associated With Worse Survival in Patients With Stage III Colon Cancer

AUGUST 20, 2025

Study Casts Doubt on the Use of Immunoglobulin Replacement Therapy for CLL

AUGUST 18, 2025

Early Detection of Pancreatic Cancer With Biomarkers Becoming a Reality

AUGUST 15, 2025

fam-trastuzumab-deruxtecan-nxki

FDA Approves First Targeted Therapy for HER2-Low Breast Cancer

The FDA approved fam-trastuzumab-deruxtecan-nxki, (Enhertu, Daiichi-Sankyo/AstraZeneca) for the treatment of ...

AUGUST 8, 2022

Load more

Check out our new Clinical tab!

We've added an exciting new feature to our website. Click on "Clinical" in the navbar to explore!

The following result is from the NPI Registry Public Search database. You can click on the NPI number to view detailed information and verify its accuracy. If your NPI is not found in this search, you can try searching again using the form below. If you have difficulty finding your NPI number please contact us at web@mcmahonmed.com

First Name

Last Name

OR

Organization/Institution

State

NPI	Name	Organization/ Institution	State	Zip Code	Taxonomy	Credential	Select